Get the latest updates on AI-powered hiring, career growth, and technical deep-dives delivered to your inbox.
Deciphera Pharmaceuticals
Deciphera, a member of Ono Pharmaceutical Co., Ltd., is a biopharmaceutical company focused on discovering, developing, and commercializing important new medicines and providing hope to people living with cancer, neurologic and autoimmune disease. Deciphera is leveraging its proprietary switch-control kinase inhibitor platform and deep expertise in kinase biology to develop a broad portfolio of innovative medicines.
In addition to advancing multiple product candidates from Deciphera’s platform in clinical studies, QINLOCK® (ripretinib) is Deciphera’s switch-control kinase inhibitor approved in many countries including the European Union and the United States for the treatment of adult patients with advanced gastrointestinal stromal tumor (GIST) who have received prior treatment with 3 or more kinase inhibitors, including imatinib.
ROMVIMZA® (vimseltinib) is a kinase inhibitor approved in the United States for adult patients with symptomatic tenosynovial giant cell tumor (TGCT) for which surgical resection will potentially cause worsening functional limitation or severe morbidity, and in the European Union for adult patients with TGCT associated with clinically relevant physical function deterioration and in whom surgical options have been exhausted or would induce unacceptable morbidity or disability.
The spirit of collaboration that has brought medications to life continues to guide how we operate, grow, and discover new breakthroughs. We cultivate an inclusive culture that values curiosity, creativity, and shared accountability—empowering individuals to challenge the unknown together.
Deciphera offers competitive compensation, including equity-based compensation, and a comprehensive benefits package that includes medical, dental, vision, 401(k) retirement plan, life insurance and a flexible spending account for either health care and/or dependent care.
Deciphera is seeking an experienced and highly motivated Territory Manager with a passion for building customer partnerships and preparing for the anticipated launch of tirabrutinib, a highly potent and selective Bruton tyrosine kinase (BTK) inhibitor being advanced for patients with relapsed or refractory primary central nervous system lymphoma (R/R PCNSL). PCNSL is a rare and aggressive extra-nodal non-Hodgkin lymphoma with significant unmet need, and tirabrutinib represents an important potential new treatment option for patients facing limited therapeutic choices.
The Territory Manager will be responsible for developing and executing a territory business plan, building strong relationships with key customers and treatment centers, and partnering closely with cross-functional stakeholders to support launch readiness and help bring tirabrutinib to patients in need.
This role requires the ability to provide disease education on PCNSL, communicate the clinical profile of tirabrutinib, describe pivotal data in a clear and compelling manner, and address both clinical and non-clinical barriers that may impact treatment adoption and patient access.
The Territory Manager will also be expected to bring forward market insights, adapt quickly to changing launch dynamics, and contribute to a seamless experience for providers and patients within the assigned geography.
Territory / Work Location: This is a field-based role. Candidates must reside within the assigned territory to effectively support customer coverage and travel requirements. Assigned territory is PA, OH, MD, DE
Deciphera is committed to fair and equitable compensation practices. The base salary pay range for this role is $176,800 - $243,236. Actual compensation packages will depend on various factors, including, but not limited to depth of experience, education, skillset, overall performance and/or location.
Deciphera believes in providing a competitive compensation and benefits package to all employees. Our base salary is just one component of Deciphera’s competitive total rewards strategy that also includes annual performance bonus, a long-term incentive plan, full range of benefits and other incentive compensation plans (if applicable)
Deciphera is committed to equal employment opportunity and values diversity. To ensure that we comply with reporting requirements, we invite you complete the confidential survey at the end of this application. Providing this information is optional. It will not be accessible or used in the hiring process, and has no effect on your opportunity for employment. This information will also be treated confidentially.
We are committed to make all hiring decisions and other employment decisions on a non-discriminatory basis.
Most resumes get rejected by the ATS before a human sees them. Check yours free in 30 seconds.
Matched to your profile
We surface this role because it matches profiles like yours, not because we vet the employer. Always confirm the pay, location, and remote details on Deciphera Pharmaceuticals's official site before you apply.
Most large employers screen resumes with software before a recruiter ever sees them. Check yours against this role in seconds. Free, no sign-up.
See the exact keywords from this posting your resume is missing, with an instant ATS score.
Open free toolUpload your CV for an instant 0-100 score and the fixes recruiters and ATS look for.
Open free toolGenerate a clean, single-column resume that parses correctly and gets past the filters.
Open free toolOther live openings in the same field. All are still accepting applications.
Keller North America, Inc.
New Orleans, LA
The Roosevelt Hotel
New Orleans, LA
Amrize
Baton Rouge, LA
Claire's
Baton Rouge, LA
Ford Motor Company
Baton Rouge, LA
1915 South | Ashley
Baton Rouge, LA